Skip to content

Effects on blood pressure of conventional strength training, handgrip training and combined training (strength training + handgrip training)

Cardiovascular Effects of Dynamic, Isometric and Combined (Dynamic + Isometric) Resistance Training in Hypertension

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4fgknb
Enrollment
Unknown
Registered
2019-12-05
Start date
2019-02-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Hypertensive men between 30 e 65 years old will be randomly divided in 4 groups that will train three tomes per week for 10 weeks Group dynamic resistance training – 3 set o moderate fatigue at 50% of
Other
F01.145.632

Sponsors

Escola de Educação Física e Esporte da Universidade de São Paulo
Lead Sponsor
Laboratório de Hipertensão do Hospital das Clínicas da Faculdade de Medicina da USP
Collaborator

Eligibility

Sex/Gender
Male
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Men between 30 and 65 years old; with diagnosis of hypertension and under antihypertensive medication with drug and dose maintained at least in then previous 4 months; not taking anti-hypertensive drugs that directly affect cardiac autonomic regulation (such as beta-blockers and non-dihydropyridine calcium channels inhibitors); not practicing physical exercise more than twice a week or more than 150 minutes/week; no resistance exercise practice in the previous 6 months.

Exclusion criteria

Exclusion criteria: Presence of secondary hypertension and/or target-organ lesion; systolic/diastolic blood pressures equal to or greater than 160/105 mmHg; obesity level II or superior; other cardiovascular diseases besides hypertension; diabetes with complications or in use of insulin; presence of osteoarticular diseases that limit resistance exercise execution; electrocardiographic alterations during maximal exercise test that suggest cardiovascular diseases; change in dose or medication during the protocol.

Design outcomes

Primary

MeasureTime frame
Decrease of clinic blood pressure measured by auscultatory technique with a minimum reduction of 4 mmHg ;Decrease of ambulatory blood pressure measured by oscillometric technique with a minimum reduction of 3 mmHg;Decrease of exercise blood pressure measured by photoplethysmographic technique with a minimum reduction of 3 mmHg

Secondary

MeasureTime frame
Improvement of cardiovascular autonomic modulation, as evidenced by the increase of heart rate variability, reduction of blood pressure variability and increase in baroreflex sensitivity measured with spectral analysis.;Improvement of the endothelial function verified by the flow-mediated dilation technique (FMD) with a minimum increase of 4% in artery diameter between the initial and final evaluations;Reduction in peripheral vascular resistance based on calculus considering the cardiac output measured by the CO2 rebreathing technique from a minimum 7% reduction between the initial and the final evaluations.

Countries

Brazil

Contacts

Public ContactClaudia Forjaz

Escola de Educação Física e Esporte da Universidade de São Paulo - EEFEUSP

cforjaz@usp.br+55(11)96335567

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 10, 2026